BOTHELL, Wash., July 8, 2011 /PRNewswire/ —
Cardiac Science Corporation, a global leader in automated
external defibrillators (
AEDs) and diagnostic
cardiac monitoring devices, announced today that the Japan
Ministry of Health, Labor, and Welfare approved a new model of its
Powerheart® G3 AED. The company is partnering with Omron
Healthcare to distribute its AEDs in Japan. Japan-based Omron is a
leading healthcare company dedicated to prevention of heart
disease.
(Logo: http://photos.prnewswire.com/prnh/20080306/AQTH510LOGO)
(Logo: http://photos.prnewswire.com/prnh/20110708/LA31990LOGO)
“We are proud to partner with Omron to distribute our Powerheart
AED in Japan,” said Dave Marver, Chief Executive Officer, Cardiac
Science Corporation. “They are a highly reputable company with an
impressive sales and service capability. We were once AED market
leaders in Japan and we look forward to reclaiming that status with
Omron as our trusted partner.”
Japan is the second largest AED market in the world with 65,000
AEDs sold annually. Cardiac Science and Omron Healthcare are
currently engaged in market launch preparations, with commercial
release and first revenue sales expected in August, 2011.
About Cardiac Science
Cardiac Science, an Opto Circuits (India)
Ltd. company, develop
‘/>”/>
SOURCE
![An illustration showing the Edwards Lifesciences Sapien M3 transcatheter mitral valve replacement (TMVR) system's valve being placed in the heart. [Image courtesy of Edwards Lifesciences]](https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2025/04/Edwards-Lifesciences-Sapien-M3-TMVR-valve-delivery-268x170.jpg)
